| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6231316 | HLA-DMA | Lung | Cell line | Calu-3 | COVID-19;COVID-19 | GSE165025 | A5SS | G0/G1 | 6 | - |
PV=1 FDR=1 FC=0.689 |
|
| 6231317 | DMAC2L | Lung | Cell line | Calu-3 | COVID-19;COVID-19 | GSE165025 | A5SS | G0/G1 | 14 | - |
PV=1 FDR=1 FC=-0.5 |
|
| 6231318 | LNPK | Lung | Cell line | Calu-3 | COVID-19;COVID-19 | GSE165025 | A5SS | G0/G1 | 2 | - |
PV=0.757 FDR=1 FC=0.039 |
|
| 6231319 | RWDD2B | Lung | Cell line | Calu-3 | COVID-19;COVID-19 | GSE165025 | A5SS | G0/G1 | 21 | - |
PV=1 FDR=1 FC=1 |
